SB 493 — Relating to protection of certain disclosures and communications by pharmacists and pharmacies regarding prescription drug benefits.
Last action — Effective on 9/1/25
Write to your legislator about it: a free email template →
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
✓Passed Senate
-
✓Passed House
-
✓To Executive
-
6Enacted
This bill has been enacted into law. Introduced November 22, 2024. Enacted.
Signed by Governor Greg Abbott (Republican) on June 20, 2025.
Summary
Relating to certain protected disclosures or communications by pharmacists and pharmacies regarding prescription drug benefits.
In the bill's own words, from its opening clause.
Bill Text
What changed in the latest version
48 added · 27 removedPlain-language change summary
The amendment adds a new section, 4151.155, to the Insurance Code, which explicitly protects certain disclosures and communications made by pharmacists or pharmacies. It prohibits pharmacy benefit managers from restricting pharmacists from informing enrollees about the cost differences of a prescription drug under their benefit plan and out-of-pocket costs that do not require a claim to be submitted. Additionally, it voids any contract provisions that prevent pharmacists from communicating with plan sponsors regarding various aspects of prescription drug benefits. This change is significant as it ensures that pharmacists can provide important cost information and facilitate communication about drug benefits, potentially aiding consumers in making informed decisions about their medications.
By:AAKolkhorst, Cook S.B.ANo.A493 AAAAASparks A BILL TO BE ENTITLED AN ACT relating to certainprotection protectedof certain disclosures orand communications by pharmacists and pharmacies regarding prescription drug benefits.
SECTIONA1.AASubchapter A,D, Chapter 562,4151, OccupationsInsurance Code, is amended by adding Section 562.00354151.155 to read as follows:
A562.0035.AAPROTECTEDA4151.155.AACERTAIN DISCLOSURES AND COMMUNICATIONS BY PHARMACISTSPHARMACIST ANDOR PHARMACIESPHARMACY REGARDINGPROTECTED. PRESCRIPTION DRUG BENEFITS.
(a) InA thispharmacy section,benefit "enrollee"manager meansmay not, by contract or otherwise, prohibit or restrict a pharmacist or pharmacy from informing an individualenrollee whoof isany covereddifference underbetween the enrollee ’s out-of-pocket cost for a healthprescription drug under the enrollee’s prescription drug benefit plan,and includingthe out-of-pocket cost without submitting a coveredclaim dependent.under the enrollee ’s prescription drug benefit.
(b)AAA(b) pharmacistAAA orprovision pharmacyin maya notpharmacy enterbenefit intomanager’ as contractpharmacy orbenefit agreementnetwork orcontract implementis orvoid effectuateand aunenforceable policyif thatthe provision prohibits or restricts thea pharmacist or pharmacy from:
(1)AAinforming an enrollee of any difference between the enrollee s out-of-pocket cost for a prescription drug under the enrollee’senrollee healths benefitprescription plandrug benefit and the out-of-pocket cost without submitting a claim under the enrollee’senrollee health’s benefitprescription plan;drug benefit;
or (2)AAcommunicating with plan sponsors ofor anadministrators enrollee’ s health benefit plan regarding member services with respect to S.B.ANo.A493 prescription drug benefits, pharmacy services and benefits, network access and adequacy with respect to prescription drug benefits, partnership opportunities, or prescription claim reimbursement.
SECTIONSECTIONA2.AAThe A2.AAThe change in law made by this Act applies only S.B.ANo.A493 to a contract or agreement entered intointo, amended, or amendedrenewed on or after the effective date of this Act.
S.B.ANo.A493 ______________________________AAAA______________________________ President of the SenateAAAAAAAAAAAAASpeaker of the House I hereby certify that S.B.ANo.A493 passed the Senate on AprilA10,A2025, by the following vote:
YeasA30, NaysA0;
and that the Senate concurred in House amendment on May A22,A2025, by the following vote:
YeasA31, NaysA0.
______________________________ AAAASecretary of the Senate I hereby certify that S.B.
ANo.A493 passed the House, with amendment, on MayA20,A2025, by the following vote:
YeasA147, NaysA0, two present not voting.
______________________________ AAAAChief Clerk of the House Approved:
______________________________ AAAAAAAAAAAAADate ______________________________ AAAAAAAAAAAGovernor 3
Action History
-
Effective on 9/1/25
-
Signed by the Governor
-
Sent to the Governor
-
Signed in the House
-
Signed in the Senate
-
Reported enrolled
-
Senate concurs in House amendment(s)-reported
-
Record vote
-
Senate concurs in House amendment(s)
-
Read
-
House amendment(s) laid before the Senate
-
House passage as amended reported
-
Record vote
-
Passed
-
Read 3rd time
-
Statement(s) of vote recorded in Journal
-
Record vote
-
Passed to 3rd reading
-
Read 2nd time
-
Placed on General State Calendar
-
Considered in Calendars
-
Committee report sent to Calendars
-
Committee report distributed
-
Comte report filed with Committee Coordinator
-
Reported favorably as substituted
-
Committee substitute considered in committee
-
Considered in formal meeting
-
Left pending in committee
-
Testimony taken/registration(s) recorded in committee
-
Considered in public hearing
-
Referred to Insurance
-
Read first time
-
Received from the Senate
-
Reported engrossed
-
Record vote
-
Passed
-
Read 3rd time
-
Record vote
-
Three day rule suspended
-
Vote recorded in Journal
-
Read 2nd time & passed to engrossment
-
Laid before the Senate
-
Placed on local & uncontested calendar
-
Co-author authorized
-
Co-author authorized
-
Co-author authorized
-
Committee report printed and distributed
-
Recommended for local & uncontested calendar
-
Reported favorably as substituted
-
Vote taken in committee
-
Considered in public hearing
-
Left pending in committee
-
Testimony taken in committee
-
Considered in public hearing
-
Scheduled for public hearing on . . .
-
Referred to Health & Human Services
-
Read first time
-
Filed
-
Received by the Secretary of the Senate
Sponsors
- Lois Kolkhorst · Primary
- César Blanco · Cosponsor
- Kevin Sparks · Cosponsor
- Royce West · Cosponsor
- Trey Wharton · Primary
- Molly Cook · Cosponsor
Sponsorship breakdown
Export CSV (upgrade) →2 sponsors · 4 co-sponsors · 178 not signed on
Sponsors (2)
- Lois Kolkhorst Republican
- Trey Wharton Republican
Co-sponsors (4)
- César Blanco Democratic
- Kevin Sparks Republican
- Royce West Democratic
- Molly Cook Democratic
Not signed on (178)
178 members have not signed on to this bill.
Show all 178 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Committees
- Senate Health and Human Services Referred February 03, 2025
- House Insurance Referred April 22, 2025
- House Calendars Referred May 14, 2025
Subjects
Frequently asked questions
- What does SB 493 do?
- Relating to certain protected disclosures or communications by pharmacists and pharmacies regarding prescription drug benefits.
- Who sponsors SB 493?
- SB 493 is sponsored by Lois Kolkhorst (Republican), César Blanco (Democratic), Kevin Sparks (Republican), Royce West (Democratic), Trey Wharton (Republican), and Molly Cook (Democratic).
- What is the current status of SB 493?
- This bill has been enacted into law. Introduced November 22, 2024. Enacted.
- Where can I track SB 493?
- Track SB 493 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 493
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 493
Last checked for changes 18 days ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →